Ainscow Robert, the Chief Operating Officer of ASP Isotopes Inc., recently sold 22,500 shares of the company's common stock. This transaction occurred on October 14, 2026, and was part of a trading plan established to cover tax withholding obligations linked to the vesting of restricted stock awards.
This sale is significant as it highlights ongoing management activity within ASP Isotopes, a company engaged in the miscellaneous chemical products sector. Such transactions can influence investor sentiment and market perceptions of the company.
Background
ASP Isotopes Inc. is categorized under the SIC code for miscellaneous chemical products. The company is incorporated in Delaware and has a fiscal year ending on December 31. Its business address is located at 2200 Ross Avenue, Suite 4575E, Dallas, Texas.
What the Filing Says
The recent filing indicates that Ainscow sold the shares at a weighted average price of $2.114, with individual transaction prices ranging from $2.05 to $2.22. The filing notes: "Represents 'sell to cover' sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on June 9, 2025 to cover tax withholding obligations in connection with the vesting of restricted stock awards."
Impact
This transaction may affect ASP Isotopes Inc.'s investors and stakeholders as it reflects the company's internal management strategies and financial planning. The sale of shares by a high-ranking officer can lead to varying interpretations regarding the company's performance and future outlook.
What's Next
The filing does not say what happens next.